000 | 01080 a2200337 4500 | ||
---|---|---|---|
005 | 20250512214825.0 | ||
264 | 0 | _c19841017 | |
008 | 198410s 0 0 eng d | ||
022 | _a0722-2211 | ||
024 | 7 |
_a10.1007/BF02014882 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKatznelson, D | |
245 | 0 | 0 |
_aFosfomycin in the treatment of cystic fibrosis. _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology _cJun 1984 |
||
300 |
_a213 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFosfomycin _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
700 | 1 | _aYahav, Y | |
700 | 1 | _aRubinstein, E | |
773 | 0 |
_tEuropean journal of clinical microbiology _gvol. 3 _gno. 3 _gp. 213 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02014882 _zAvailable from publisher's website |
999 |
_c6468243 _d6468243 |